Structures by: Madura I. D.
Total: 37
Catena-(bis(/m2-beta-Alanine)-lithium perchlotate)
C6H14LiN2O4,ClO4
CrystEngComm (2020)
a=8.3651(6)Å b=9.9433(7)Å c=27.584(2)Å
α=90° β=90° γ=90°
Catena-(/m-3-beta-Alanine-lithium perchlorate)
C3H7ClLiNO6
CrystEngComm (2020)
a=24.143(3)Å b=5.0111(7)Å c=14.528(2)Å
α=90° β=125.825(3)° γ=90°
Catena-(bis(/m-2-beta-Alanine)-lithium perchlorate)
C6H14LiN2O4,ClO4
CrystEngComm (2020)
a=4.9667(6)Å b=8.4410(11)Å c=13.9410(18)Å
α=90° β=95.899(4)° γ=90°
(Benzene-1,2-diolato)(methanolato)(2-(morpholinomethyl)phenyl)boron methanol solvate
C18H22BNO4,CH4O
New Journal of Chemistry (2013) 37, 1 188
a=13.1083(3)Å b=9.45522(19)Å c=15.1358(4)Å
α=90.00° β=99.016(2)° γ=90.00°
2-((4-phenylpiperazin-1-yl)methyl)phenylboronic acid
C17H21BN2O2
New J. Chem. (2015) 39, 6 4308
a=13.3088(2)Å b=6.01200(10)Å c=19.8330(2)Å
α=90.00° β=108.6467(14)° γ=90.00°
2-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)phenylboronic acid
C18H23BN2O3
New J. Chem. (2015) 39, 6 4308
a=12.1978(3)Å b=19.2053(5)Å c=15.5424(4)Å
α=90.00° β=96.000(3)° γ=90.00°
2-((4-(2,3-dichlorophenyl)piperazin-1-yl)methyl)phenylboronic acid
C17H19BCl2N2O2
New J. Chem. (2015) 39, 6 4308
a=7.9155(4)Å b=10.3130(4)Å c=11.8333(7)Å
α=88.456(4)° β=72.897(5)° γ=69.370(4)°
2-((4-(4-nitrophenyl)piperazin-1-yl)methyl)phenylboronic acid
C17H20BN3O4
New J. Chem. (2015) 39, 6 4308
a=10.32568(6)Å b=9.10656(10)Å c=18.03844(12)Å
α=90.00° β=90.7068(6)° γ=90.00°
2-((4-methylpiperazin-1-yl)methyl)phenylboronic acid
C12H19BN2O2,H2O
New J. Chem. (2015) 39, 6 4308
a=12.87751(17)Å b=10.18562(12)Å c=10.36536(14)Å
α=90.00° β=90.00° γ=90.00°
2-((4-benzhydrylpiperazin-1-yl)methyl)phenylboronic acid
C24H27BN2O2,C3H6O
New J. Chem. (2015) 39, 6 4308
a=24.60371(16)Å b=11.76829(7)Å c=17.52165(11)Å
α=90.00° β=93.8287(6)° γ=90.00°
3-methyl-1-phenyl-4-(p-tolylselanyl)-1H-pyrazol-5-amine
C17H17N3Se
RSC Advances (2019) 9, 44 25368
a=12.5515(5)Å b=5.93199(19)Å c=21.5896(11)Å
α=90° β=101.138(4)° γ=90°
4-((2-fluorphenyl)selanyl)-3-methyl-1-phenyl-1H-pyrazol-5-amine
C16H14FN3Se
RSC Advances (2019) 9, 44 25368
a=10.7344(4)Å b=11.4734(4)Å c=13.5667(5)Å
α=92.850(3)° β=109.342(3)° γ=97.713(3)°
3-methyl-1-phenyl-4-((3-trifluoromethyl)phenyl)selanyl)-1H-pyrazol-5-amine
C17H14F3N3Se
RSC Advances (2019) 9, 44 25368
a=5.7537(2)Å b=23.2453(8)Å c=12.4112(5)Å
α=90° β=90.937(4)° γ=90°
3-methyl-4-((3-nitrophenyl)selanyl)-1-phenyl-1H-pyrazol-5-amine
C16H14N4O2Se
RSC Advances (2019) 9, 44 25368
a=8.0441(3)Å b=16.3997(6)Å c=12.5446(5)Å
α=90° β=106.994(4)° γ=90°
4-((2-bromophenyl)selanyl)-3-methyl-1-phenyl-1H-pyrazol-5-amine
C16H14BrN3Se
RSC Advances (2019) 9, 44 25368
a=9.4439(4)Å b=26.1410(11)Å c=12.8829(4)Å
α=90° β=91.719(3)° γ=90°
Methyl 2-((5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)selanyl)benzoate
C18H17N3O2Se
RSC Advances (2019) 9, 44 25368
a=12.6478(10)Å b=10.1017(8)Å c=26.833(3)Å
α=90° β=90° γ=90°
3-bromo-2-(1-phenetyl)-4-nitro-1H-pyrazol-3-yl)selanyl)pyridine
C16H13BrN4O2Se
RSC Advances (2019) 9, 44 25368
a=7.8948(5)Å b=7.9369(6)Å c=31.3002(16)Å
α=83.404(5)° β=89.627(5)° γ=60.612(7)°
1-(4-ethylbenzyl)-4-nitro-3-(p-tolylselanyl)pyridine
C19H19N3O2Se
RSC Advances (2019) 9, 44 25368
a=4.8207(3)Å b=36.9783(15)Å c=10.4021(6)Å
α=90° β=95.860(6)° γ=90°
N-fluorenyl-methylen-xycarbonyl-O-tert-butyl-N-methyl-tyrosine; Fmoc-N-Me-Tyr(t-Bu)-OH
C29H31NO5
Acta Crystallographica Section C (2020) 76, 4
a=6.4917(3)Å b=17.5357(7)Å c=22.2418(8)Å
α=90° β=90° γ=90°
4-bromo-2-nitroaniline
C6H5BrN2O2
Acta Crystallographica Section C (2018) 74, 11
a=11.1643(11)Å b=3.8275(4)Å c=17.2764(16)Å
α=90° β=98.662(3)° γ=90°
2-bromo-6-nitroaniline
C6H5BrN2O2
Acta Crystallographica Section C (2018) 74, 11
a=4.4477(2)Å b=11.4469(4)Å c=13.8244(5)Å
α=90° β=94.635(2)° γ=90°
3,4,5-Triflurophenylboronic acid--urea (1/1)
C6H4BF3O2,CH4N2O
Acta Crystallographica Section C (2017) 73, 11 889-895
a=11.5305(6)Å b=8.2823(4)Å c=11.5020(6)Å
α=90° β=118.304(7)° γ=90°
(S)-pantolactone-O,O'-diacetyl-(R,R)-hydrogentartrate O,O'-diacetyl-(R,R)-hydrogentartrate-(S)-3,3-dimethylbutyrolakton-2-yl O,O'-diacetyl-(R,R)-hydrogentartrate ester of (S)-pantolactone
C14H18O10
Acta Crystallographica Section E (2007) 63, 7 o3209-o3209
a=7.946(2)Å b=13.067(3)Å c=16.796(3)Å
α=90.00° β=90.00° γ=90.00°
(R)-pantolactone-O,O'-diacetyl-(R,R)-hydrogentartrate monohydrate O,O'-diacetyl-(R,R)-hydrogentartrate-(R)-3,3-dimethylbutyrolakton-2-yl monohydrate O,O'-diacetyl-(R,R)-hydrogentartrate ester of (R)-pantolactone monohydrate
C14H18O10,H2O
Acta Crystallographica Section E (2007) 63, 7 o3210-o3210
a=8.2882(15)Å b=12.905(3)Å c=16.544(4)Å
α=90.00° β=90.00° γ=90.00°
Deacetylcephalothin
C14H14N2O5S2
Acta Crystallographica Section C (2005) 61, 11 o625-o627
a=9.6992(18)Å b=6.4069(12)Å c=12.919(2)Å
α=90.00° β=93.974(14)° γ=90.00°
1-(4-methoxyphenyl)-2,2-dimethylpropan-1-ol
C12H18O2
Acta Crystallographica Section C (2007) 63, 12 o720-o722
a=20.8868(6)Å b=6.00175(18)Å c=17.3531(5)Å
α=90.00° β=90.00° γ=90.00°
2,4-dimethylbenzoic acid
C9H10O2
Acta Crystallographica Section C (2008) 64, 4 o208-o210
a=5.4656(12)Å b=13.660(2)Å c=10.6755(19)Å
α=90.00° β=99.182(16)° γ=90.00°
P-fluorbenzoxaborole
C7H6BFO2
Acta Crystallographica Section E (2011) 67, 2 o414-o415
a=3.8799(3)Å b=6.3077(5)Å c=14.0735(12)Å
α=98.068(7)° β=91.564(7)° γ=100.473(7)°
(2<i>R</i>,3<i>R</i>)-3-<i>O</i>-Benzoyl-<i>N</i>-benzyltartramide
C18H17NO6
Acta Crystallographica Section E (2012) 68, 6 o1891-o1892
a=35.7118(6)Å b=6.17734(11)Å c=7.48599(15)Å
α=90.00° β=93.0377(15)° γ=90.00°
O-fluorophenylboronic acid
C6H6BFO2
Crystal Growth & Design (2014) 14, 11 5912
a=5.10172(16)Å b=5.55660(17)Å c=22.0587(7)Å
α=90.00° β=94.731(3)° γ=90.00°
O,m-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=8.96573(17)Å b=4.95730(8)Å c=29.7170(5)Å
α=90° β=97.5927(16)° γ=90°
Diorthofluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=5.02719(16)Å b=5.39423(15)Å c=23.2334(7)Å
α=90.00° β=91.897(3)° γ=90.00°
O,m,p-trifluorophenylboronic acid
C6H4BF3O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.3762(3)Å b=5.0241(3)Å c=15.6401(11)Å
α=96.483(6)° β=94.143(6)° γ=92.835(6)°
O,o,p-trifluorophenylboronic acid
C6H4BF3O2
Crystal Growth & Design (2014) 14, 11 5912
a=5.00301(10)Å b=5.33367(10)Å c=24.2178(4)Å
α=90.00° β=90.2585(17)° γ=90.00°
2,5-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.15299(7)Å b=5.11382(9)Å c=30.7324(5)Å
α=90° β=90.0696(14)° γ=90°
2,5-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=4.9578(4)Å b=5.5256(4)Å c=23.484(2)Å
α=90° β=93.974(8)° γ=90°
2,4-difluorophenylboronic acid
C6H5BF2O2
Crystal Growth & Design (2014) 14, 11 5912
a=3.67926(11)Å b=12.2868(4)Å c=14.3179(4)Å
α=90° β=93.057(3)° γ=90°